Primary Site >> Stomach Cancer

Gene >> EGLN3

Journal: Med Oncol. 2012 Dec;29(4):2710-5.
Title: Overexpression of the HIF hydroxylase PHD3 is a favorable prognosticator for gastric cancer.
Author: Su, Changlei|Huang, Kejin|Sun, Lingyu|Yang, Dongdong|Zheng, Hongqun|Gao, Changlu|Tong, Jinxue|Zhang, Qifan
PMID: 22290580
Journal: Mol Carcinog. 2014 Sep;53(9):736-43.
Title: Prolyl hydroxylase 3 inhibited the tumorigenecity of gastric cancer cells.
Author: Cui, Lei|Qu, Jianguo|Dang, Shengchun|Mao, Zhengfa|Wang, Xuqing|Fan, Xin|Sun, Kang|Zhang, Jianxin
PMID: 23533015
Journal: Mol Med Rep. 2017 Nov;16(5):6882-6889.
Title: PHD3 affects gastric cancer progression by negatively regulating HIF1A.
Author: Xia, Ying-Jie|Jiang, Xiao-Ting|Jiang, Shi-Bin|He, Xu-Jun|Luo, Jun-Gang|Liu, Zheng-Chuang|Wang, Liang|Tao, Hou-Quan|Chen, Jian-Zhong
PMID: 28901473
Journal: FASEB J. 2018 Oct;32(10):5378-5389.
Title: Acetylation-mediated Siah2 stabilization enhances PHD3 degradation in Helicobacter pylori-infected gastric epithelial cancer cells.
Author: Kokate, Shrikant Babanrao|Dixit, Pragyesh|Das, Lopamudra|Rath, Suvasmita|Roy, Arjama Dhar|Poirah, Indrajit|Chakraborty, Debashish|Rout, Niranjan|Singh, Shivaram Prasad|Bhattacharyya, Asima
PMID: 29688807